You are on page 1of 2


1. Ari A. Aerosol Therapy in Pulmonary Critical Care. Respiratory Care. 2015;60(6):

2. Bajwa SS, Baruah MP, Kalra S, Kapoor MK. Guidelines on Inpatient Management of
Hyperglycemia. In: Muruganathan A. (ed.) Medicine Update. Vol. 23. Mumbai:
Association of Physicians of India; 2013: 164–169.
3. Bilgrami I, Roberts JA, Wallis SC, Thomas J, Davis J, Fowler S. Meropenem Dosing
in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous
Hemofiltration. Antimicrobial Agents and Chemotherapy. 2010;54(7): 2974–2978.
4. Bhagat A, Rachana. Bromhexine: A Comprehensive Review. International Journal of
Biological and Medical Research. 2018;9(3): 6455–6459.
5. Chang CC, Cheng AC, Chang AB. Over-the-Counter (OTC) Medications to Reduce
Cough as An Adjunct to Antibiotics for Acute Pneumonia in Children and Adults.
Cochrane Database of Systematic Reviews. 2014;3(CD006088).
6. Ciesla WP, Guerrant RL. Infectious Diarrhea. In: Wilson WR, Drew WL, Henry NK,
et al editors. Current Diagnosis and Treatment in Infectious Disease. New York: Lange
Medical Books, 2003. 225 - 68.
7. DuPont HL, Ericsson CD, DuPont MW, Cruz Luna A, Mathewson JJ. A randomized,
open-label comparison of nonprescription loperamide and attapulgite in the
symptomatic treatment of acute diarrhea. The American Journal of Medicine. 1990; 88:
20S – 23S.
8. Febyan F, Tanpomas I, Suparto. Sepsis dan Tatalaksana Berdasar Guideline Terbaru.
Jurnal Anestesiologi Indonesia. 2018;X(2): 102.
9. Freitag D, Bebee R, Sunderland B. Digoxin-quinidine and digoxine-amiodarone
interactions: frequency of occurence and monitoring in Australian repatriation
hospitals. Journal of Clinical Pharmacy and Therapeutics. 1995;20: 179–183
10. Guerrant RL, Gilder TV, Steiner TS, et al. Practice Guidelines for the Management of
Infectious Diarrhea. Clinical Infectious Diseases 2001;32:331-51.
11. Gustaviani reno, Suyono slamet, Soebardi suharko, Waspadji sarwono,Yunir em,
Soegondo sidartawan. Buku ajar ilmu penyakit dalam jilid III edisi 4. Diabetes mellitus
di Indonesia, diagnosis dan klasifikasi diabetes, farmakoterapi dan terapi non
farmakologis DM tipe 2, komplikasi kronik diabetes. Jakarta : FKUI; 2007 h. 1852-86.
12. Giamarellos-Bourboulis EJ, Spyridaki A, Savva A, Georgitsi M, Tsaganos T, et al.
Intravenous Paracetamol as an Antipyretic and Analgesic Medication: the Significance
of Drug Metabolism. Journal of Pharmacological Sciences. 2014;124: 144–152.
13. Gorji HM, Gorji NM, Vasel A, Rahimi B. The Effect of Proton Pump Inhibitors on
Glycemic Control in Patients with Type II Diabetes. Journal of Clinical and Analytical
Medicine. 2017;8(Supplement 5): 504–508.
14. Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy.
Pediatrics. 1957;19(5): 823–832.
15. In: Gallo A, et al, editors. Intensive and Critical Care Medicine. Springer-Verlag Italia,
2009; p. 299-309.
16. Lung E, Acute Diarrheal Disease. In: Friedman SL, McQuaid KR, Grendell JH, editors.
Current Diagnosis and Treatment in Gastroenterology. 2 edition. New York: Lange
Medical Books, 2003. 131 - 50.
17. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014
AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation.
Journal of the American College of Cardiology. 2014;64(21): e1–e76.
18. Nathalie M, Dhainaut JF. Sepsis and acute lung injury. In: Dhainaut JF, et al, editors.
Septic shock. WB Saunders Company Limited, 2000; p. 211–45.
19. Nebraska Medicine. Antibiotic Protocol for Empiric Therapy of Community-Acquired
Pneumonia (CAP). Omaha, NE: Nebraska Medicine; 2015.
20. Nguyen B, et al. Severe sepsis and septic shock: Review of the literature and
emergency. Department management guidelines. Annals of Emergency Medicine.
2006; 48(1): 28-54.
21. Orbach S, et al. The pa! ent with sepsis or the Systemic Inflamatory Respons
Syndrome. In: Murray MJ, et al, editors. Critical care medicine: Perioperative
management. 2nd ed. Lippinco' Williams&Wilkins, 2002; p. 601-15.
22. Pedoman Pemberantasan Penyakit Diare. Mentri Kesehatan Republik Indonesia.
Available from :
23. Rani A.Aziz, Nafrialdi, dkk. Panduan Pelayanan Medik PB PAPDI. Jakarta :
Departemen Ilmu Penyakit Dalam FKUI, Agustus 2008.
24. Prakash S, Aggarwal M. Rate of Administration of Intravenous Ondansetron. Indian
Journal of Anaesthesia. 2011;55(4): 426–427.
25. PDR. Seftriakson. Tersedia di
seftriakson-1723.4059. Diakses 11 Desember 2018.
Peker E, Cagan E, Dogan M. Ceftriaxone-induced Toxic Hepatitis. World Journal of
Gastroenterology. 2009;15(21): 2669-2671.